Navigation Links
Ibuprofen Linked to Reduced Alzheimer's Risk
Date:5/5/2008

Other painkillers show some benefit, but more research needed, study says

MONDAY, May 5 (HealthDay News) -- People who use the painkiller ibuprofen regularly for five years may be less likely to develop Alzheimer's disease as they age, a new study suggests.

And more generally, people using the class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs) may have a decreased risk for Alzheimer's as well, although the link here is not as clear-cut as it is for ibuprofen.

But the findings don't put to rest a debate that has long simmered about the role of NSAIDs in the prevention or treatment of Alzheimer's, given the gastrointestinal side effects associated with long-term use of this class of painkillers.

"This discussion has been going on for a while," said William Thies, vice president of medical and scientific relations for the Alzheimer's Association. "This trial is big enough and the results are good enough that it may reopen the debate -- that we should do a prevention study with these medications."

But at this point, the conclusions aren't firm enough to start taking ibuprofen or any other NSAID to help ward off dementia, he said.

"Probably people shouldn't be taking these medications just to prevent Alzheimer's. The effect is too uncertain and the side effects are pretty well known," Thies said. "For those people who won't listen to this advice, they should be really careful to fill in their physician so he can track it with other medications."

Dr. Steven Vlad, lead author of the study and a fellow in rheumatology at Boston University School of Medicine, agreed, saying: "The big issue is that ibuprofen looks like it prevents Alzheimer's but all these drugs have well-known side effects and significant side effects, so the risk-benefit ratio is not clear at this point. Patients shouldn't go on ibuprofen to prevent Alzheimer's."

The findings are published in the May 6 issue of Neurology.

While so-called epidemiological studies have indicated some dementia prevention benefit with NSAIDs and ibuprofen, treatment trials have shown no benefits.

The new study involved five years of data on 50,000 U.S. veterans aged 55 and older who had a diagnosis of Alzheimer's. A control group included almost 200,000 veterans without an Alzheimer's diagnosis.

Overall, people who used NSAIDs long-term were at a lower risk of developing Alzheimer's -- about 25 percent lower. But the benefit was more pronounced with specific drugs.

The risk of developing Alzheimer's decreased the longer a person used ibuprofen, with those using the drug for five years more than 40 percent less likely to develop this dementia.

"It's not clear what the mechanisms are," Vlad said. It may have to do with reducing inflammation in the brain, reducing a component of the plaques which are a hallmark of Alzheimer's, or some as-yet unidentified process, he added.

"A clinical trial of ibuprofen for the prevention of Alzheimer's disease would be reasonable to get the risks and benefits," Vlad said. "There's also going to be ongoing research into developing drugs like ibuprofen without the toxicities."

A second study in the same issue of the journal, by U.S. researchers involved with the Cardiovascular Health Cognition Study, found that people with shorter limbs may have a higher risk of developing dementia.

Among women, greater knee height (measured from the sole of the foot to the front of the thigh) and arm span (the distance between fingertips) were linked with a decreased risk of dementia (16 percent decreased risk per 1-inch increase for knee height, and a 7 percent decrease per 1-inch increase in arm span).

Overall, women with the shortest arm spans were 1.5 times more likely to develop dementia, including Alzheimer's, compared with women who had longer arm spans, the study said.

Among men, only arm span was associated with a lower risk of dementia: a 6 percent decreased risk for every one-inch increase.

The researchers suggested that poor nutrition may have much to do with the possible link. According to the researchers, poor nutrition in early life and other factors could influence intelligence and levels of education and, eventually, risk of dementia.

In this study, men and women with longer measurements had had more years of education; height has also been linked with intelligence.

More information

Visit the Alzheimer's Association for more on this brain disorder.



SOURCES: Steven Vlad, M.D., fellow, rheumatology, Boston University School of Medicine; William Thies, Ph.D., vice president, medical and scientific relations, Alzheimer's Association, Chicago; May 6, 2008, Neurology


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Ibuprofen destroys aspirins positive effect on stroke risk
2. Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis
3. Ibuprofen associated with slower lung function decline in children with cystic fibrosis
4. Albemarle to Increase Price of Ibuprofen
5. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
6. Mental disorders in parents linked to autism in children
7. Physical activity, healthy eating and BMI not linked in older teens: study
8. Genes Linked to Osteoporosis Identified
9. Higher Wealth Linked to Lower Risk of Early Stroke
10. Social form of bullying linked to depression, anxiety in adults
11. Antipsychotic Drugs Linked to Pneumonia in Elderly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... , ... SABRE is raising awareness about personal safety with a Chicago Transit ... , The Chicago, Illinois, based self-defense brand has been waiting for an opportunity like ... taking their personal safety into their own hands. , The ads focus on their ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device ... staying in compliance with FDA rules. , The FDA has issued two draft ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a ... public health departments have been awarded five-year accreditation status through the Public ... of being served by a PHAB-accredited health department now extend to more ...
(Date:9/21/2017)... ... ... In addition to sticking with the new years goal ... use natural alternatives for all house cleaning products, disinfectants, respiratory relief, and much ... new line of essential oils, are all 100% organic and natural. , Combine ...
(Date:9/21/2017)... ... September 21, 2017 , ... The New England Center for Children® (NECC®), a ... of Yie-Hsin Hung to the Board of Directors. , “The New England Center ... Hung is an invaluable addition to our team,” said Vincent Strully, Jr., President and ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)...  Getinge, a leading global provider of innovative ... program -- "Color for the Kids!" -- to ... by The Children,s Heart Foundation. Pediatric patients and ... encouraged to download a coloring picture at ... the gallery on the website. For each artwork ...
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
Breaking Medicine Technology: